title: Hyperuricemia in Tendons.
abstract: Hyperuricemia, particularly gout, and the immune inflammatory response are highly integrated. Both, long standing hyperuricemia and monosodium urate (MSU) crystal deposition can challenge tendon homeostasis because of their potential to cause inflammation to the host. Knowledge is emerging from clinical imaging research depicting where MSU crystals deposit, including patellar tendon, triceps and quadriceps tendons. Remarkably, subclinical tendon inflammation and damage are also present in asymptomatic hyperuricemia. Monosodium urate crystals act as danger activating molecular patterns (DAMPs), activating the inflammasome and inducing the secretion of IL-1beta, a key mediator of the inflammatory response. The crucial role of IL-1beta in driving the inflammatory events during gout attacks is supported by the clinical efficacy of IL-1beta blockade. Some data implicating IL-1beta as an initiator of tendinopathy exist, but the link between hyperuricemia and the development of tendinopathy remains to be validated. Further knowledge about the interactions of uric acid with both innate immune and tendon cells, and their consequences may help to determine if there is a subclass of hyperuricemic-tendinopathy.
authors.affiliation: Regenerative Medicine Laboratory, BioCruces Health Research Institute, Cruces University Hospital, 48903, Barakaldo, Spain. iandia2010@hotmail.com.
authors.forename: Isabel
authors.initials: I
authors.lastname: Andia
authors.affiliation: Department of Medicine and Science of Aging, University G. d'Annunzio, Via dei Vestini 31, Chieti-Pescara, 66013, Chieti Scalo (CH), Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Abate
mesh_terms: D006801:Humans; D033461:Hyperuricemia / Q000175:diagnosis / Q000209:etiology*; D052256:Tendinopathy / Q000150:complications* / Q000378:metabolism; D013710:Tendons / Q000503:physiopathology*; D014527:Uric Acid / Q000378:metabolism*
chemical_list: D014527:Uric Acid